Nutritional Assessment (Week 2 Lecture 2) Flashcards

1
Q

prevalence of weight loss patterns in different cancers

A

lecture said GI cancers and lung?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes of POOR nutritional STATUS in patients WITH CANCER

A

Half of patients have some nutritional issues prior to diagnosis
* Decreased dietary intake
* Increased nutrient requirements
* Increased losses of nutrients
* Impaired nutrient digestion/ absorption (especially GI tract)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Poor nutritional status and weight loss prevalence

A

common in the oncology patients
* Oncology patients are among the most malnourished of all patient groups → In a classic paper by Dewys (1980) malnutrition ranged from 31% to 87% (40 years later no change)
* 40% of hospitalized oncology patients are malnourished
* Depending on tumour type, 32-88% of patients are at risk of malnutrition4,5,6,7
* 35-75% of lung cancer patients report unintentional weight loss prior to diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Experience of weight loss with diagnosis, anti-cancer treatment and cachexia

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why might patients experience weight loss prior to diagnosis?

A
  • They probably have other comorbidities such as diabetes or heart disease
  • More overweight or obese than general population and may be malnourished
  • Sudden stress or anxiety
  • Late stage of cancer, untreated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does weight loss in cancer primarly consist of?

A

Skeletal muscle mass - will have reduced function and cannot respond as well to treatment and may not get treatment they need, will have more toxicities
* cachexia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

cachexia in cancer

A

defined as a “multifactorial syndrome characterized by an ongoing loss of skeletal muscle mass that cannot be fully reversed by conventional nutritional support, and leads to progressive functional impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What should assessment tools consider in nutritional assessments?

A
  • Easy to use clinically - inexpensive, yes/no
  • Rapid classification
  • Captures all patients who require further nutritional support
  • Validated in the population of interest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the similarities and differences between MNA and PG-SGA?

A
  • similar: has subjective questions about food intake, weight change, physical activities
  • Different: SGA assess weight loss more strictly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Screening for nutritional status

A
  • Energy Intake
  • Biochemistries/biological measures
  • Symptom assessment (i.e. ESAS) - Edmonton Systems Assessment Survey
  • Functional status (i.e. FAACT) - Functional Assessment of Anorexia Chacexia Therapy
  • Measures of immunity and/or inflammation
  • Anthropometry
  • EORTC - QoL questionairre
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some ways that
body composition can be measured?

A
  • DEXA - small dose of radiation considered trivial (less than what you get in airplane)
  • MRI
  • Anthro - skin folds, MAMC, weight and height
  • CT imaging (can see all the different tissues)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is considered the best method for assessing body composition in cancer patients?

A

CT analysis → Usually do an image just at site of tumour area to prevent full body radiation
* Usually upper body at 3rd lumbar (upper body) because this is proportional to entire body
* fat free tissue: bone tissue, liver, kidneys, spleen tumour, intestines, specific skeletal muscle groups.
* fat tissue: visceral, intramuscular, subcutaneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is intrabdominal fat considered

A

pathological in nature
* except for those around kidney whic are for shock absorption fat pad

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why is muscle mass loss important?

A

Weight and muscle Loss affects prognosis. Many patients report some degree of weight loss in the 2-6 months prior to receiving treatment leading to:
* Poorer response to treatment
* Poor prognosis and even worse during chemotherapy
* Lung cancer patients treated with chemoradiation who had >5% weight loss within the first three weeks of treatment had decreased overall survival (13 vs. 23 months, p=0.017)
* Weight loss >2.4% is significantly related to decreased survival especially unintended (often related to malginancy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Causes of Muscle mass loss in patient with cancer

A
  • chronic or acute illness
  • poor oral intake and weight loss
  • advanced age
  • inactivity
  • inflammation
  • T2D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does age-related loss of muscle mass look like in normal subjects

A

4% per decade in men and 3% per decade in women
* Even if active would still lose muscle but less severely

17
Q

Outcomes of muscle mass loss in cancer patients

A
  • ANOREXIA
  • FATIGUE
  • MUSCLE DECONDITIONING
  • EXCESS PROTEOLYSIS
  • EXCESS LIPOLYSIS
  • FUTILE CYCLING
18
Q

Loss of muscle mass contributes to

A
  • Greater decline in physical function
  • Decreased Health Related Quality of Life (dependant care)
  • Greater toxicities of chemotherapy (get knocked out)
  • Negative impact on treatment completion
  • Decreased performance status
  • Increased fatigue (cognitive, failure to produce ATP)
  • Reduced muscle strength
  • Impaired wound healing (higher infection risk)
19
Q

Nutritional status and muscle loss affecting quality of life

A

Nutritional status (and intake) are independent determinants of QoL as much as stage of disease, location of the cancer and treatment regimen in some types of cancer.
Patients rated 50% of their QoL to nutrition related outcomes
* Dietary intake
* Weight loss

20
Q

What is low muscle mass a predictor/ indicator of?

A

Low muscle mass may be even more important to outcomes
* Low muscle mass is common and independent predictor of immobility and mortality
* Low muscle mass is an independent adverse prognostic indicator in obese patients

21
Q

Aim of guidelines for nutrition intervention and optimizing muscle mass in oncology patients

A

Translate current evidence and expert opinion into recommendations for the multi-disciplinary team responsible for prevention, identification and treatment of reversible elements of malnutrition in cancer patients and contribute to decreasing the risk of cancer recurrence.

22
Q

What is GRADE?

A

Grading of Recommendations, Assessment, Development and Evaluations

23
Q

What are the certainty’s for GRADE and there meanings?

A
24
Q

What is included for guidelines on nutrition for patients with cancer?

A
  • Screening
  • assessment
  • energy requirements
  • protein intake
  • exercise in combination with nutrition & type of exercise recommended
25
Q

screening guidelines

A
26
Q

assessment guidelines

A
27
Q

energy requirement guidelines

A
28
Q

Protein Intake Guidelines

A
29
Q

Exercise guidelines

A
30
Q

Nutrition recommendations

A
  • energy
  • protein
  • other nutrients
31
Q

What do oss of weight and mean muscle mass affect?

A
  • strength
  • QoL
  • tolerance to treatment
  • survival